(Q83052427)

English

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma

scientific article published on 01 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

peritoneal carcinoma

1 reference

based on heuristic

inferred from title

1

object named as

Dennis S Chi

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Richard R Barakat

10

object named as

Richard R Barakat

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

object named as

Yukio Sonoda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nadeem R. Abu-Rustum

5

object named as

Nadeem R Abu-Rustum

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Oliver Zivanovic

2

object named as

Oliver Zivanovic

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Douglas A Levine

7

object named as

Douglas A Levine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Eric L Eisenhauer

4

object named as

Eric L Eisenhauer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Meena J Palayekar

3

object named as

Meena J Palayekar

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

9

object named as

Carol L Brown

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Mario M Leitao

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

112

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6-10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Epithelial ovarian carcinoma: principles of primary surgery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Identification of prognostic factors in advanced epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC–IV epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Factors associated with cytoreducibility among women with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Predicting "unresectable" ovarian cancer: Taking aim at a moving target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.10.010

7 January 2021

Identifiers

10.1016/J.YGYNO.2008.10.010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19100916%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83052427&oldid=2046349750"